Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-14, with 37 holding rows worth $122,124,000.

Accession
0001420506-21-000690
Filed
2021-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 37 entries on the cover page, a total value of $122,124,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $122,124,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PROTHENA CORP PLC SHSG72800108Stock600,000$15,072,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM38,350$8,241,000thousands by filing date
ENCOMPASS HEALTH CORP COM29261A100Stock100,000$8,190,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW105,828$7,343,000thousands by filing date
CUE BIOPHARMA INC22978P106COM556,777$6,793,000thousands by filing date
Bristol-Myers Squibb Company110122108COM95,600$6,035,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK170,352$6,005,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM473,446$5,625,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR66,419$5,120,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock360,834$4,685,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM750,310$4,472,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK291,944$4,213,000thousands by filing date
ZOGENIX INC.98978L204Common Stock195,000$3,806,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock21,197$3,393,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO450,165$2,976,000thousands by filing date
OSCAR HEALTH INC687793109CL A107,086$2,878,000thousands by filing date
CELLECTIS ADS15117K103COM137,900$2,787,000thousands by filing date
INOVALON HLDGS INC45781D101COM CL A85,000$2,446,000thousands by filing date
Medtronic PlcG5960L103COM20,088$2,373,000thousands by filing date
UnitedHealth Group Inc91324P102COM6,000$2,232,000thousands by filing date
CARA THERAPEUTICS INC140755109COM100,000$2,171,000thousands by filing date
METACRINE INC59101E103COM304,485$1,888,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock320,100$1,770,000thousands by filing date
LHC GROUP50187A107COM8,783$1,679,000thousands by filing date
AKUMIN INC01021F109COM429,061$1,588,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM17,000$1,361,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM8,685$1,328,000thousands by filing date
ONCORUS INC68236R103COM70,807$986,000thousands by filing date
APTOSE BIOSCIENCES INC COM03835T200Stock150,000$896,000thousands by filing date
ADMA BIOLOGICS INC000899104COM497,842$876,000thousands by filing date
EXICURE INC30205M101COM275,848$601,000thousands by filing date
SIO GENE THERAPIES INC829399104COM205,900$537,000thousands by filing date
BAXTER INTL INC071813109COM5,800$489,000thousands by filing date
ODONATE THERAPEUTICS INC676079106COM117,621$402,000thousands by filing date
MORPHIC HLDG INC61775R105COM5,202$329,000thousands by filing date
ORGANOGENESIS HOLDINGS INC68621F102COMMON STOCK15,232$278,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM56,500$260,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-21-000690this filing2021-05-14acceptance time not in the bulk data set